Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018 (2018), Article ID 8104165, 10 pages
https://doi.org/10.1155/2018/8104165
Research Article

Black Seed Thymoquinone Improved Insulin Secretion, Hepatic Glycogen Storage, and Oxidative Stress in Streptozotocin-Induced Diabetic Male Wistar Rats

1Department of Physiology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt
2Department of Clinical Pathology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt
3Department of Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
4Zoology Department, Faculty of Sciences, Suez Canal University, Ismailia, Egypt
5Department of Biochemistry, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt
6Department of Basic Medical Sciences, College of Applied Medical Sciences, University of Bisha, Bisha, Saudi Arabia

Correspondence should be addressed to Heba M. A. Abdelrazek; moc.liamg@tevkezarledbaabeh

Received 28 October 2017; Accepted 19 December 2017; Published 4 March 2018

Academic Editor: Lotfi Aleya

Copyright © 2018 Heba M. A. Abdelrazek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Kumar and M. Clark, “Diabetes mellitus and other disorders of metabolism,” Clinical Medicine, vol. 2, pp. 1069–1071, 2002. View at Google Scholar
  2. American Diabetes Association, “Economic costs of diabetes in the U.S. in 2012,” Diabetes Care, vol. 36, no. 4, pp. 1033–1046, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Luis-Rodríguez, A. Martínez-Castelao, J. L. Górriz, F. De-Álvaro, and J. F. Navarro-González, “Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy,” World Journal of Diabetes, vol. 3, no. 1, pp. 7–18, 2012. View at Publisher · View at Google Scholar
  4. A. Sturza, O. M. Duicu, A. Vaduva et al., “Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes,” Canadian Journal of Physiology and Pharmacology, vol. 93, no. 7, pp. 555–561, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. B. S. Karam, A. Chavez-Moreno, W. Koh, J. G. Akar, and F. G. Akar, “Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes,” Cardiovascular Diabetology, vol. 16, no. 1, p. 120, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Zorzano, W. Wilkinson, N. Kotliar et al., “Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations,” Journal of Biological Chemistry, vol. 264, no. 21, pp. 12358–12363, 1989. View at Google Scholar
  7. A. Belfiore, F. Frasca, G. Pandini, L. Sciacca, and R. Vigneri, “Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease,” Endocrine Reviews, vol. 30, no. 6, pp. 586–623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. S. Schwartz, “Optimizing glycemic control and minimizing the risk of hypoglycemia in patients with type 2 diabetes,” Drugs in Context, vol. 2013, article 212255, 8 pages, 2013. View at Google Scholar
  9. H. Nasri, H. Shirzad, A. Baradaran, and M. Rafieian-kopaei, “Antioxidant plants and diabetes mellitus,” Journal of Research in Medical Sciences, vol. 20, no. 5, pp. 491–502, 2015. View at Publisher · View at Google Scholar
  10. S. K. Basha, G. Sudarsanam, M. S. Mohammad, and N. Parveen, “Investigations on anti-diabetic medicinal plants used by Sugali tribal inhabitants of Yerramalais of Kurnool district, Andhra Pradesh India,” Stamford Journal of Pharmaceutical Sciences, vol. 4, no. 2, 2012. View at Publisher · View at Google Scholar
  11. R. B. Kasetti, M. D. Rajasekhar, V. K. Kondeti et al., “Antihyperglycemic and antihyperlipidemic activities of methanol: water (4, 1) fraction isolated from aqueous extract of Syzygium alternifolium seeds in streptozotocin induced diabetic rats,” Food and Chemical Toxicology, vol. 48, no. 4, pp. 1078–1084, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Goreja, Black Seed: Nature's Miracle Remedy, Amazing Herbs Press, New York, NY, USA, 2003.
  13. H. Ijaz, U. R. Tulain, J. Qureshi et al., “Nigella sativa (prophetic medicine): a review,” Pakistan Journal of Pharmaceutical Sciences, vol. 30, no. 1, 2017. View at Google Scholar
  14. L. Canonica, G. Jommi, C. Scolastico, and A. Bonati, “The pharmacologically active principle in Nigella sativa,” Gazzetta Chimica Italiana, vol. 93, pp. 1404–1407, 1963. View at Google Scholar
  15. J. Danladi, A. Abdusalam, J. Timbuak, A. Miriga, and A. Dahiru, “Hepatoprotective effect of black seed (Nigella sativa) oil on carbon tetrachloride (CCl4) induced liver toxicity in adult Wistar rats,” IOSR Journal of Dental and Medical Sciences, vol. 4, no. 3, pp. 56–62, 2013. View at Publisher · View at Google Scholar
  16. M. M. Abdel-Daim and E. W. Ghazy, “Effects of Nigella sativa oil and ascorbic acid against oxytetracycline-induced hepato-renal toxicity in rabbits,” Iranian Journal of Basic Medical Sciences, vol. 18, no. 3, pp. 221–227, 2015. View at Google Scholar
  17. Z. Gholamnezhad, H. Rafatpanah, H. R. Sadeghnia, and M. H. Boskabady, “Immunomodulatory and cytotoxic effects of Nigella sativa and thymoquinone on rat splenocytes,” Food and Chemical Toxicology, vol. 86, Supplement C, pp. 72–80, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. A. M. S. Gani and S. A. John, “Effect of Nigella sativa L. on liver enzymes and kidney morphology on D-GalN induced toxicity in rats,” World Journal of Pharmacy and Phamaceutical Sciences, vol. 5, no. 12, pp. 1193–1200, 2016. View at Google Scholar
  19. H. A. El Rabey, M. N. Al-Seeni, and A. S. Bakhashwain, “The antidiabetic activity of Nigella sativa and propolis on streptozotocin-induced diabetes and diabetic nephropathy in male rats,” Evidence-based Complementary and Alternative Medicine, vol. 2017, Article ID 5439645, 14 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Beheshti, M. Khazaei, and M. Hosseini, “Neuropharmacological effects of Nigella sativa,” Avicenna Journal of Phytomedicine, vol. 6, no. 1, pp. 104–116, 2016. View at Google Scholar
  21. A. F. Majdalawieh and M. W. Fayyad, “Recent advances on the anti-cancer properties of Nigella sativa, a widely used food additive,” Journal of Ayurveda and Integrative Medicine, vol. 7, no. 3, pp. 173–180, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Hosseinzadeh and S. Parvardeh, “Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice,” Phytomedicine, vol. 11, no. 1, pp. 56–64, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Meddah, R. Ducroc, M. El Abbes Faouzi et al., “Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats,” Journal of Ethnopharmacology, vol. 121, no. 3, pp. 419–424, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. K. Mahmoud, S. Y. Saleh, A. Abd El Rehim, and I. A. Ibrahim, “Biochemical efficacy of Nigella sativa oil and metformin on induced diabetic male rats,” American Journal of Animal and Veterinary Sciences, vol. 9, no. 4, pp. 277–284, 2014. View at Publisher · View at Google Scholar
  25. M. Balbaa, M. El-Zeftawy, D. Ghareeb, N. Taha, and A. W. Mandour, “Nigella sativa relieves the altered insulin receptor signaling in streptozotocin-induced diabetic rats fed with a high-fat diet,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 2492107, 16 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. N. W. Tietz, Tietz Clinical Guide to Laboratory Tests, WB Saunders Company, Philadelphia, PA, USA, 1990.
  27. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Tietze, “Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues,” Analytical Biochemistry, vol. 27, no. 3, pp. 502–522, 1969. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Bancroft and M. Gamble, “Hematoxylin and eosin, connective tissue and stain, carbohydrates,” in Theory and Practice in Histological Techniques, pp. 121–186, Churchill-Livingstone, Edinburgh, 6th edition, 2008. View at Google Scholar
  30. A. G. E. Pearse, “Histochemistry,” Theoretical and Applied, vol. 1, pp. 1–759, 1968. View at Google Scholar
  31. S. O. Adewole and J. A. O. Ojewole, “Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 29, no. 7, pp. 447–455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. R. A. R. Elgawish, H. G. A. Rahman, and H. M. A. Abdelrazek, “Green tea extract attenuates CCl4-induced hepatic injury in male hamsters via inhibition of lipid peroxidation and p53-mediated apoptosis,” Toxicology Reports, vol. 2, Supplement C, pp. 1149–1156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Ramakrishna and R. Jailkhani, “Evaluation of oxidative stress in insulin dependent diabetes mellitus (IDDM) patients,” Diagnostic Pathology, vol. 2, no. 1, p. 22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. T. van Bremen, D. Drömann, K. Luitjens et al., “Triggering receptor expressed on myeloid cells-1 (Trem-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsis,” Diagnostic Pathology, vol. 8, no. 1, p. 24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. M. Forbes, M. T. Coughlan, and M. E. Cooper, “Oxidative stress as a major culprit in kidney disease in diabetes,” Diabetes, vol. 57, no. 6, pp. 1446–1454, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Huynh, B. C. Bernardo, J. R. McMullen, and R. H. Ritchie, “Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways,” Pharmacology & Therapeutics, vol. 142, no. 3, pp. 375–415, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Tag Hend, M. A. Abdelazek Heba, S. Mahoud Yasmen, and S. el Shenawy Nahla, “Efficacy of Tribulus terrestris extract and metformin on fertility indices and oxidative stress of testicular tissue in streptozotocin-induced diabetic male rats,” African Journal of Pharmacy and Pharmacology, vol. 9, no. 48, pp. 1088–1098, 2015. View at Publisher · View at Google Scholar
  38. N. M. Omar and G. M. Atia, “Effect of Nigella sativa on pancreatic β-cell damage in streptozotocin-induced diabetic rats,” The Egyptian Journal of Histology, vol. 35, no. 1, pp. 106–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. K. K. Wong and E. S. Tzeng, “Appearance of different diabetic symptoms after streptozotocin administration: a comparison study,” Biochemistry and Molecular Biology International, vol. 30, no. 6, pp. 1035–1041, 1993. View at Google Scholar
  40. A. Doğan and İ. Çelik, “Healing effects of sumac (Rhus coriaria) in streptozotocin-induced diabetic rats,” Pharmaceutical Biology, vol. 54, no. 10, pp. 2092–2102, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Kanter, O. Coskun, A. Korkmaz, and S. Oter, “Effects of Nigella sativa on oxidative stress and β-cell damage in streptozotocin-induced diabetic rats,” The Anatomical Record, vol. 279, no. 1, pp. 685–691, 2004. View at Publisher · View at Google Scholar
  42. M. Kaleem, D. Kirmani, M. Asif, Q. Ahmed, and B. Bano, Biochemical Effects of Nigella sativa L Seeds in Diabetic Rats, 2006.
  43. Z. Houcher, K. Boudiaf, M. Benboubetra, and B. Houcher, “Effects of methanolic extract and commercial oil of Nigella sativa L. on blood glucose and antioxidant capacity in alloxan-induced diabetic rats,” Pteridines, vol. 18, no. 1, 2007. View at Publisher · View at Google Scholar
  44. T. Szkudelski, “The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas,” Physiological Research, vol. 50, no. 6, pp. 537–546, 2001. View at Google Scholar
  45. K. M. Fararh, Y. Atoji, Y. Shimizu, T. Shiina, H. Nikami, and T. Takewaki, “Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters,” Research in Veterinary Science, vol. 77, no. 2, pp. 123–129, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Rchid, H. Chevassus, R. Nmila et al., “Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated Langerhans islets,” Fundamental & Clinical Pharmacology, vol. 18, no. 5, pp. 525–529, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. K. M. Fararh, Y. Atoji, Y. Shimizu, and T. Takewaki, “Isulinotropic properties of Nigella sativa oil in streptozotocin plus nicotinamide diabetic hamster,” Research in Veterinary Science, vol. 73, no. 3, pp. 279–282, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. K. M. S. Mansi, “Effects of oral administration of water extract of Nigella sativa on serum concentrations of insulin and testosterone in alloxan-induced diabetic rats,” Pakistan Journal of Biological Sciences, vol. 8, no. 8, pp. 1152–1156, 2005. View at Publisher · View at Google Scholar
  49. B. Krishnamurthy, J. Chee, G. Jhala et al., “Complete diabetes protection despite delayed thymic tolerance in NOD8.3 TCR transgenic mice due to antigen-induced extrathymic deletion of T cells,” Diabetes, vol. 61, no. 2, pp. 425–435, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. K. A. Coughlan, R. J. Valentine, N. B. Ruderman, and A. K. Saha, “AMPK activation: a therapeutic target for type 2 diabetes?” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 7, p. 241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. D. F. Horrobin, “The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, vol. 31, no. 3, pp. 181–197, 1988. View at Google Scholar
  52. I. J. Goldberg, “Diabetic dyslipidemia: causes and consequences,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 3, pp. 965–971, 2001. View at Publisher · View at Google Scholar
  53. Y. Kocyigit, Y. Atamer, and E. Uysal, “The effect of dietary supplementation of Nigella sativa L. on serum lipid profile in rats,” Saudi Medical Journal, vol. 30, no. 7, pp. 893–896, 2009. View at Google Scholar
  54. M. Ismail, G. Al-Naqeep, and K. W. Chan, “Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats,” Free Radical Biology and Medicine, vol. 48, no. 5, pp. 664–672, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Al-Naqeeb and M. Ismail, “Regulation of apolipoprotein A-1 and apolipoprotein B100 genes by thymoquinone rich fraction and thymoquinone in HEPG2 cells,” Journal of Food Lipids, vol. 16, no. 2, pp. 245–258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Ahmad and Z. H. Beg, “Hypolipidemic and antioxidant activities of thymoquinone and limonene in atherogenic suspension fed rats,” Food Chemistry, vol. 138, no. 2-3, pp. 1116–1124, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. J. W. Baynes, “Role of oxidative stress in development of complications in diabetes,” Diabetes, vol. 40, no. 4, pp. 405–412, 1991. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Tsimikas and Y. I. Miller, “Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease,” Current Pharmaceutical Design, vol. 17, no. 1, pp. 27–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. O. E. Kelany, H. E. Khaled, M. Amal, H. M. Abdelrazek, and M. M. Abdel-Daim, “Hepatoprotective and metabolic effects of dietary soy phytoestrogens against hyper caloric diet in cyclic female albino rats is mediated through estradiol receptors beta,” Biomedical and Pharmacology Journal, vol. 10, no. 3, pp. 1061–1069, 2017. View at Publisher · View at Google Scholar
  60. I. Meral, Z. Yener, T. Kahraman, and N. Mert, “Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defence system and liver damage in experimentally-induced diabetic rabbits,” Journal of Veterinary Medicine Series A, vol. 48, no. 10, pp. 593–599, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. S. O. Adewole, E. A. Caxton-Martins, and J. A. Ojewole, “Protective effect of quercetin on the morphology of pancreatic β-cells of streptozotocin-treated diabetic rats,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 4, no. 1, pp. 64–74, 2007. View at Publisher · View at Google Scholar
  62. A. Gökçe, S. Oktar, A. Koc, and Z. Yonden, “Protective effects of thymoquinone against methotrexate-induced testicular injury,” Human & Experimental Toxicology, vol. 30, no. 8, pp. 897–903, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. O. A. Badary, A. B. Abdel-Naim, M. H. Abdel-Wahab, and F. M. Hamada, “The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats,” Toxicology, vol. 143, no. 3, pp. 219–226, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. G. P. Widodo, R. Herowati, J. M. Perangin-Angin, and J. E. Kamlasi, “Antihyperglycemic, antioxidant, and pancreas regeneration activities of black cumin (Nigella sativa L.) seeds ethanol extract in alloxan-induced diabetic rats,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 5, pp. 37–40, 2016. View at Google Scholar
  65. R. H. Tuhin, M. M. Begum, M. S. Rahman et al., “Wound healing effect of Euphorbia hirta Linn. (Euphorbiaceae) in alloxan induced diabetic rats,” BMC Complementary and Alternative Medicine, vol. 17, no. 1, p. 423, 2017. View at Publisher · View at Google Scholar · View at Scopus
  66. M. G. Bischof, E. Bernroider, M. Krssak et al., “Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia,” Diabetes, vol. 51, no. 1, pp. 49–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. A. R. Saltiel and C. R. Kahn, “Insulin signalling and the regulation of glucose and lipid metabolism,” Nature, vol. 414, no. 6865, pp. 799–806, 2001. View at Publisher · View at Google Scholar · View at Scopus